329 filings
8-K
GALT
Galectin Therapeutics Inc
29 Mar 24
Galectin Therapeutics Reports 2023 Financial Results and Provides Business Update
7:55am
8-K
GALT
Galectin Therapeutics Inc
11 Dec 23
Submission of Matters to a Vote of Security Holders
4:15pm
8-K
GALT
Galectin Therapeutics Inc
7 Dec 23
Regulation FD Disclosure
11:42am
8-K
GALT
Galectin Therapeutics Inc
13 Nov 23
Results of Operations and Financial Condition
7:55am
8-K
GALT
Galectin Therapeutics Inc
14 Aug 23
Results of Operations and Financial Condition
7:55am
8-K
qyvctbg
15 May 23
Results of Operations and Financial Condition
7:55am
8-K
w79pqacax9
30 Mar 23
Galectin Therapeutics Reports 2022 Financial Results and Provides Business Update
7:54am
8-K
xawru
2 Mar 23
Other Events
7:55am
8-K
o6z99i3w
5 Jan 23
Other Events
7:55am
8-K
pho2 fc5xb47sq
6 Dec 22
Submission of Matters to a Vote of Security Holders
8:00am
8-K
scqo4yb7b3m4ljj
1 Dec 22
Regulation FD Disclosure
11:00am
8-K
inbiwvbhkiz8prtf la
14 Nov 22
Results of Operations and Financial Condition
7:55am
8-K
h2wokx1zbbk1
12 Oct 22
Galectin Therapeutics Receives FDA Approval to Proceed with Combination Immunotherapy Trial in Head and Neck Cancer
7:50am
8-K
mupg7v5uxx0i78iej93w
6 Oct 22
Other Events
7:50am
8-K
qe0of 47j
15 Aug 22
Results of Operations and Financial Condition
7:56am
8-K
104n1x0sgkspk4 xat
26 Jul 22
Galectin Therapeutics Announces $60 Million Credit Line
7:57am
8-K
u2svi
16 May 22
Results of Operations and Financial Condition
7:55am
8-K
9ib3uzz pe
14 Apr 22
Other Events
7:50am
8-K
b1fqkpvrac7
31 Mar 22
Galectin Therapeutics Reports 2021 Financial Results and Provides Business Update
8:06am
8-K
r08sr 0oqeqq5
21 Dec 21
Galectin Therapeutics Announces Closing of $10 Million in Debt Financing from Its Chairman, Richard E. Uihlein
7:50am